Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$111.63

-3.25 (-2.83%)

15:40
01/03/19
01/03
15:40
01/03/19
15:40

$3M premium sale in Eli Lilly as shares slump

$3M premium sale in Eli Lilly as shares slump. The stock off $3.16 to $111.72 and 5.75K Apr 105 - 120 strangles trade $5.56 on ISE. Interest appears to be selling both puts and calls (for a firm account) and expressing the view that shares will likely hold between $105 and 120 through the April expiration, or not see a move greater than roughly 7% in either direction. 52-week high and low are $74.21 and $118.64. The position captures one earnings report in February.

  • 06

    Jan

  • 14

    Jan

  • 28

    Jan

  • 18

    May

LLY Eli Lilly
$111.63

-3.25 (-2.83%)

12/31/18
CANT
12/31/18
NO CHANGE
Target $53
CANT
Overweight
Doctors impressed by tanezumab data, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen says that investors she's spoken with are expecting the data for Pfizer (PFE) and Eli Lilly's (LLY) tanezumab in the first half of 2019 to be similar to or worse than what was seen in the first Phase 3 data set reported on October 23. However, physicians are impressed by the data and do not believe the rapidly progressive osteoarthritis imbalance would impact their desire to prescribe tanezumab if it is approved, Chen tells investors in a research note. The analyst believes the safety for tanezumab will be better than expected and that the drug could replace opioids for the treatment of pain. If that is right, peak sales potential of tanezumab could be billions of dollars, and drive upside to modest expectations for the drug, says the analyst. She keeps an Overweight rating on Pfizer with a $53 price target.
12/27/18
ARGS
12/27/18
NO CHANGE
Target $135
ARGS
Buy
Argus sees volume growth, expanded indications as 2019 catalysts for Eli Lilly
Argus analyst David Toung kept his Buy rating and $135 price target on Eli Lilly, saying its 2019 catalysts for upside include anticipated volume growth and expanded indications for existing drugs, along with "potential regulatory approvals". The analyst notes that while the company's mature products are seeing slower sales and face patent expiration and the loss of exclusivity, he also expects Eli Lilly to generate earnings growth from margin expansion. Toung is also confident in 2019 contribution of Eli Lilly's recently launched Olumiant for rheumatoid arthritis, Verzenio for the second-line treatment of breast cancer, and Taltz for active psoriatic arthritis.
12/24/18
BMOC
12/24/18
NO CHANGE
Target $132
BMOC
Outperform
Eli Lilly price target raised to $132 from $124 at BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Eli Lilly to $132 from $124 and kept his Outperform rating, saying that unlike its peers, the company offers "multiple growth drivers and several pipeline assets that could provide meaningful upside." The analyst anticipates Eli Lilly's annualized revenue and earnings growth of 5% and 16% with "significant upside potential" coming from Tanezumab and Alzheimer's program. Araeil further believes that the company's growth, strong R&D and commercial execution prospects "support its premium valuation."
12/20/18
LEHM
12/20/18
NO CHANGE
Target $120
LEHM
Overweight
Eli Lilly update 'bolsters bullish outlook,' says Barclays
Barclays analyst Geoff Meacham believes Eli Lilly's update yesterday bolstered its bullish outlook. The company's new product growth underscores an attractive investment case, Meacham tells investors in a research note. While the initial 2019 guidance was "solidly ahead of expectations," what is more impressive is the underlying quality, with new products set to drive 45% of 2019's growth outlook, says the analyst. He keeps an Overweight rating on Eli Lilly with a $120 price target.

TODAY'S FREE FLY STORIES

DIA

Diamonds Fund ETF

$277.76

-0.41 (-0.15%)

08:21
11/22/19
11/22
08:21
11/22/19
08:21
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$310.30

-0.5 (-0.16%)

08:21
11/22/19
11/22
08:21
11/22/19
08:21
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$29.69

-0.02 (-0.07%)

08:21
11/22/19
11/22
08:21
11/22/19
08:21
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBS

Emergent BioSolutions

$52.46

-1.9 (-3.50%)

08:20
11/22/19
11/22
08:20
11/22/19
08:20
Hot Stocks
Emergent BioSolutions presents immunogenicity results from Phase 2 study »

Emergent BioSolutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$131.14

-1.45 (-1.09%)

08:20
11/22/19
11/22
08:20
11/22/19
08:20
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$201.67

-0.45 (-0.22%)

08:20
11/22/19
11/22
08:20
11/22/19
08:20
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:20
11/22/19
11/22
08:20
11/22/19
08:20
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:20
11/22/19
11/22
08:20
11/22/19
08:20
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$65.17

0.12 (0.18%)

, SQM

SQM

$23.29

-0.12 (-0.51%)

08:19
11/22/19
11/22
08:19
11/22/19
08:19
Recommendations
Albemarle, SQM analyst commentary  »

Albemarle price target…

ALB

Albemarle

$65.17

0.12 (0.18%)

SQM

SQM

$23.29

-0.12 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

PSTG

Pure Storage

$19.84

-0.22 (-1.10%)

08:17
11/22/19
11/22
08:17
11/22/19
08:17
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 09

    Dec

  • 12

    Dec

  • 10

    Mar

  • 11

    Mar

CGC

Canopy Growth

$20.28

2.65 (15.03%)

, ACB

Aurora Cannabis

$3.12

0.48 (18.18%)

08:16
11/22/19
11/22
08:16
11/22/19
08:16
Recommendations
Canopy Growth, Aurora Cannabis analyst commentary  »

Canopy Growth, Aurora…

CGC

Canopy Growth

$20.28

2.65 (15.03%)

ACB

Aurora Cannabis

$3.12

0.48 (18.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMPY

Amplify Energy

$5.60

-0.11 (-1.93%)

08:13
11/22/19
11/22
08:13
11/22/19
08:13
Initiation
Amplify Energy initiated  »

Amplify Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OLED

Universal Display

$197.75

-2.57 (-1.28%)

08:11
11/22/19
11/22
08:11
11/22/19
08:11
Downgrade
Universal Display rating change  »

Universal Display…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AB

AllianceBernstein

$29.23

-0.06 (-0.20%)

, CI

Cigna

$201.29

1.45 (0.73%)

08:11
11/22/19
11/22
08:11
11/22/19
08:11
Conference/Events
Gabelli to hold a conference »

Healthcare at a…

AB

AllianceBernstein

$29.23

-0.06 (-0.20%)

CI

Cigna

$201.29

1.45 (0.73%)

JNJ

Johnson & Johnson

$136.46

0.58 (0.43%)

PFE

Pfizer

$37.74

0.69 (1.86%)

WBA

Walgreens Boots Alliance

$60.59

-0.75 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 07

    Dec

  • 09

    Dec

  • 11

    Dec

  • 21

    Jan

  • 06

    Feb

PEG

PSEG

$60.72

-0.47 (-0.77%)

08:10
11/22/19
11/22
08:10
11/22/19
08:10
Hot Stocks
PSEG announces Ralph LaRossa as COO, Sheila Rostiac as CDO »

PSEG announced several…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VG

Vonage

$7.46

0.25 (3.47%)

, SAP

SAP

$135.56

0.59 (0.44%)

08:10
11/22/19
11/22
08:10
11/22/19
08:10
Recommendations
Vonage, SAP analyst commentary  »

Investors should be…

VG

Vonage

$7.46

0.25 (3.47%)

SAP

SAP

$135.56

0.59 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 09

    Dec

AHCO

AdaptHealth

$8.11

-0.64 (-7.31%)

, MCK

McKesson

$152.35

1.69 (1.12%)

08:09
11/22/19
11/22
08:09
11/22/19
08:09
Hot Stocks
AdaptHealth agrees to acquire PCS business from McKesson »

AdaptHealth (AHCO)…

AHCO

AdaptHealth

$8.11

-0.64 (-7.31%)

MCK

McKesson

$152.35

1.69 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODP

Office Depot

$2.38

0.075 (3.25%)

, AN

AutoNation

$51.45

-0.45 (-0.87%)

08:07
11/22/19
11/22
08:07
11/22/19
08:07
Hot Stocks
Office Depot CFO Joseph Lower to leave Jan. 10 to become CFO of AutoNation »

Office Depot (ODP)…

ODP

Office Depot

$2.38

0.075 (3.25%)

AN

AutoNation

$51.45

-0.45 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JACK

Jack in the Box

$80.75

-4.14 (-4.88%)

08:06
11/22/19
11/22
08:06
11/22/19
08:06
Recommendations
Jack in the Box analyst commentary  »

Jack in the Box price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$51.45

-0.45 (-0.87%)

, ODP

Office Depot

$2.38

0.075 (3.25%)

08:04
11/22/19
11/22
08:04
11/22/19
08:04
Hot Stocks
AutoNation appoints Joseph Lower CFO »

AutoNation (AN) announced…

AN

AutoNation

$51.45

-0.45 (-0.87%)

ODP

Office Depot

$2.38

0.075 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFRMF

Future Farm

$0.00

(0.00%)

08:04
11/22/19
11/22
08:04
11/22/19
08:04
Hot Stocks
Future Farm completes drying, curing of hemp, seeds in Maine »

Future Farm Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$9.22

-0.28 (-2.95%)

, CMCSA

Comcast

$44.37

0.15 (0.34%)

08:03
11/22/19
11/22
08:03
11/22/19
08:03
Recommendations
Lionsgate, Comcast analyst commentary  »

Lionsgate price target…

LGF.A

Lionsgate

$9.22

-0.28 (-2.95%)

CMCSA

Comcast

$44.37

0.15 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

HCI

HCI Group

$44.54

-0.86 (-1.89%)

08:03
11/22/19
11/22
08:03
11/22/19
08:03
Hot Stocks
HCI Group announces TypTap surpasses $50M in premiums »

HCI Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

ZTS

Zoetis

$120.25

0.75 (0.63%)

08:01
11/22/19
11/22
08:01
11/22/19
08:01
Hot Stocks
Zoetis acquires ZNLabs, terms not disclosed »

Zoetis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VG

Vonage

$7.46

0.25 (3.47%)

, SAP

SAP

$135.56

0.59 (0.44%)

08:00
11/22/19
11/22
08:00
11/22/19
08:00
Hot Stocks
Vonage names former SAP executive as President of Applications Group »

Vonage (VG) announced…

VG

Vonage

$7.46

0.25 (3.47%)

SAP

SAP

$135.56

0.59 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.